Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology
Gohlke-Bärwolf, C.; Acar, J.; Oakley, C.; Butchart, E.; Burckhart, D.; Bodnar, E.; Hall, R.; Delahaye, J.P.; Horstkotte, D.; Krémer, R.
European Heart Journal 16(10): 1320-1330
1995
ISSN/ISBN: 0195-668X PMID: 8746900 Document Number: 440697
Document emailed within 1 workday
Related Documents
Lichodziejewska, B. 1993: Management of patients with valvular heart disease and poor ventricular function. the Working Group on Valvular Heart Disease Kardiologia Polska 39(10): 316-317Pyörälä, K.; de Backer, G.; Graham, I.; Poole-Wilson, P.; Wood, D. 1995: Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension Archives des maladies du coeur et des vaisseaux 88(10 Suppl): 1493-1542
Gohlke-Bärwolf, C.; Krémer, R. 1996: Prevention of thromboembolic events in valvular heart disease Acta Cardiologica 51(2): 129-142
Gohlke, H.; Kübler, W.; Mathes, P.; Meinertz, T.; Schuler, G.; Gysan, D.B.; Sauer, G. 2001: Recommendations for an extensive risk decrease for patients with coronary disease, vascular diseases and diabetes. Issued by the Executive Committee of the German Society of Cardiology, Heart and Circulation Research, reviewed on behalf of the Clinical Cardiology Commission by the Prevention Project Group Zeitschrift für Kardiologie 90(2): 148-149
Heinzl, S. 1993: Coronary heart disease. New guidelines of the European Society of Atherosclerosis for prevention Medizinische Monatsschrift für Pharmazeuten 16(7): 210-213
Fleck, E.; von Lutterotti, N. 1999: Reports by the German Society of Cardiology--Heart- and Cardiovascular Research. Clinical Epidemiology Working Group Zeitschrift für Kardiologie 88(9): 687-692
1989: The European Cooperative Study on the clinical significance of right heart thrombi. European Working Group on Echocardiography European Heart Journal 10(12): 1046-1059
Greszata, L.; Stępińska, J. 2015: Moderate or severe aquired valvular heart disease in pregnancy--what does determine the management? Experence, intuition or guidelines? Przeglad Lekarski 72(4): 189-192
Rothlin, M. 1995: Heart interventions in Switzerland 1992. PTCA and Fibrinolysis Study Group of the Swiss Society of Cardiology Schweizerische Medizinische Wochenschrift 125(4): 136
Sandoe, J.A.T.; Barlow, G.; Chambers, J.B.; Gammage, M.; Guleri, A.; Howard, P.; Olson, E.; Perry, J.D.; Prendergast, B.D.; Spry, M.J.; Steeds, R.P.; Tayebjee, M.H.; Watkin, R. 2015: Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE) Journal of antimicrobial chemotherapy 70(2): 325-359
Rosa, V.E.E.; Lopes, A.S.S.A.; Accorsi, T.A.D.; Fernandes, J.R.C.; Spina, G.S.; Sampaio, R.O.; Bacal, F.; Tarasoutchi, F. 2015: Heart Transplant in Patients with Predominantly Rheumatic Valvular Heart Disease Journal of Heart Valve Disease 24(5): 629-634
Sukhum, P.; McBride, J.W.; Long, L.A.; Campion, B.C. 1980: Echocardiography of valvular heart disease: evaluation of heart murmurs Minnesota Medicine 63(12): 869-877
Bodick, N.; Forette, F.; Hadler, D.; Harvey, R.J.; Leber, P.; McKeith, I.G.; Riekkinen, P.J.; Rossor, M.N.; Scheltens, P.; Shimohama, S.; Spiegel, R.; Tanaka, S.; Thal, L.J.; Urata, Y.; Whitehouse, P.; Wilcock, G. 1997: Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group Alzheimer Disease and Associated Disorders 11 Suppl. 3: 50-53
Vitali, C.; Bencivelli, W.; Isenberg, D.A.; Smolen, J.S.; Snaith, M.L.; Sciuto, M.; Neri, R.; Bombardieri, S. 1992: Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE Clinical and Experimental Rheumatology 10(5): 541-547
Barreto, E.; Linares, E.; Rivera, J.V. 1983: Coronary and valvular heart disease: gated cardiac blood pool study Boletin de la Asociacion Medica de Puerto Rico 75(6): 265-266
Savova, A.; Stoitchev, S.; Ovanesyan, H.; Finkov, B.; Belov, J. 1986: Coronary artery disease in patients with valvular heart disease Zeitschrift für Kardiologie 75(Suppl 2): 73-75
Rasmussen, V.G.; Dupont, E.; Østergaard, K.; Egeblad, H. 2006: Valvular heart disease associated with the treatment of Parkinson disease Ugeskrift for Laeger 168(26-32): 2542-2544
Michel, P.L.; Garbarz, E.; Messika-Zeitoun, D.; Roussin, I. 2000: The best of valvular heart disease in 1999 Archives des Maladies du Coeur et des Vaisseaux 93(1 Spec No): 97-102
Domenech, B.; Pomar, J.é L.; Prat-González, S.; Vidal, B.ár.; López-Soto, A.; Castella, M.; Sitges, M. 2016: Valvular Heart Disease Epidemics Journal of Heart Valve Disease 25(1): 1-7
Toyosaki, N.; Shiina, A.; Hashimoto, T.; Yamasawa, M.; Suzuki, O.; Yaginuma, T.; Hosoda, S.; Harada, M.; Kimura, S.; Hasegawa, T. 1987: Serial changes in cardiovascular dimensions and left ventricular function after surgery of valvular heart disease: a follow-up study by echocardiography Journal of Cardiology 17(1): 65-76